{
    "clinical_study": {
        "@rank": "85693", 
        "arm_group": {
            "arm_group_label": "No Treatment", 
            "description": "Collect pilot data on the performance of the ICARS in patients younger than 10 years of age, as well as to introduce definitions for the various clinically defined stages of AT, and attempt to develop descriptors of change that could help in the assessment of patients longitudinally."
        }, 
        "brief_summary": {
            "textblock": "The project will collect information on the mapping of clinical ratings on a number of\n      scales that are used in the assessment of patients with ataxias."
        }, 
        "brief_title": "International Ataxia Rating Scale in Younger Patients", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ataxia Telangiectasia", 
        "condition_browse": {
            "mesh_term": [
                "Ataxia", 
                "Ataxia Telangiectasia", 
                "Telangiectasis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria\n\n          1. Patients aged 6-18 years with diagnosed with ataxia, preferably AT will be included.\n             The diagnosis of AT will be made based on the criteria: typical clinical picture plus\n             one of the following: 1. a proven mutation in the ATM gene 2. Deficient ATM protein\n             proven by Western blotting 3. Elevated \u03b1-fetoprotein, cerebellar atrophy on MRI and\n             immune deficiency/ chromosomal breakage/ T- cell lymphoreticular malignancy.\n\n          2. Children aged 6-18 years with suspected AT (fulfilling partially the above criteria\n             will be included)\n\n          3. Children aged 6-18 years with AT like disease, with or without proven mutation in the\n             MRE11 gene will be included\n\n          4. Children aged 6-18 years of age with ataxia of other known or unknown etiologies\n             might be included, but their total number should not exceed 20% of the cohort in each\n             site"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "6 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Known patients with ataxia/ataxia telangiectasia"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942850", 
            "org_study_id": "ICARS-CGI-Ery01-2013"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 17, 2014", 
        "location": [
            {
                "contact": {
                    "email": "tzesiewi@health.usf.edu", 
                    "last_name": "Theresa A Zesiewicz, MD FAAN", 
                    "phone": "813-974-5909"
                }, 
                "contact_backup": {
                    "email": "kbarber@health.usf.edu", 
                    "last_name": "Kelly Sullivan, PhD", 
                    "phone": "(813) 974-5909"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Carol Morsani USF Health Center"
                }, 
                "investigator": {
                    "last_name": "Theresa A Zesiewicz, MD FAAN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anaaita Hedge"
                }, 
                "facility": {
                    "address": {
                        "city": "Mumbai", 
                        "country": "India"
                    }, 
                    "name": "Jaslok Hospital"
                }, 
                "investigator": {
                    "last_name": "Anaaita Hedge, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "andreea.nissenkorn@sheba.health.gov.il", 
                    "last_name": "Andreea Nissenkorn, MD", 
                    "phone": "972-3530-5061"
                }, 
                "facility": {
                    "address": {
                        "city": "Tel Hashomer", 
                        "country": "Israel"
                    }, 
                    "name": "Edmond and Lilly Safra Childrens Hospital Pediatric Unit"
                }, 
                "investigator": {
                    "last_name": "Andreea Nissenkorn, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "micheli.roby@tin.it", 
                    "last_name": "Roberto Micheli, MD", 
                    "phone": "39-030-3995721"
                }, 
                "facility": {
                    "address": {
                        "city": "Brescia", 
                        "country": "Italy"
                    }, 
                    "name": "A.O Spedalli Civilli Brescia"
                }, 
                "investigator": {
                    "last_name": "Roberto Micheli, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "India", 
                "Israel", 
                "Italy"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "APPLICABILITY OF THE INTERNATIONAL ATAXIA RATING SCALE (ICARS) IN YOUNGER PATIENTS AND DEVELOPMENT OF GLOBAL RATING INSTRUMENTS FOR PATIENTS WITH ATAXIA TELANGIECTASIA (AT)", 
        "overall_contact": {
            "email": "luca.benatti@erydel.com", 
            "last_name": "Luca Benatti, MD"
        }, 
        "overall_contact_backup": {
            "email": "msidlowski@clinirx.com", 
            "last_name": "Marian Sidlowski"
        }, 
        "overall_official": {
            "affiliation": "Erydel", 
            "last_name": "Luca Benatti, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: Ethics Committee", 
                "Israel: Ethics Commission", 
                "India: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome is validity of ICARS in children younger than 10 years of age (by comparing the mean scores and subscores between children aged 6-10 years of age to those aged 10-18 years of age).", 
            "measure": "Correlation Analysis", 
            "safety_issue": "No", 
            "time_frame": "single visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942850"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Erydel", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Erydel", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}